Statement: the primary clinical trial's intervention strategy consists of the administration of avastin, bevacizumab and radiation therapy to the participants
Primary_evidence: INTERVENTION 1:    Avastin (Bevacizumab) Plus Hormone   All patients received Avastin (Bevacizumab) 15 mg/kg IV every three weeks as well as continuing with hormonal therapy they previously were taking.